Neurovative Diagnostics

What Neurovative Diagnostics does

Neurovative Diagnostics is a Dallas-based private company founded in 2016 that provides in-home ambulatory video EEG (electroencephalogram) and long-term monitoring services to hospitals, physicians, private practices, and patients. The company operates a cloud-based platform that allows technologists to remotely review EEG studies and report findings back to referring providers, with Joint Commission accreditation and acceptance of Medicare, Medicaid, Tricare, and all major commercial insurance plans. The service model centers on dispatching monitoring equipment to patients' homes, downloading studies, and delivering interpretive results through the cloud platform, with intermittent EEG monitoring pioneered by the company in 2016 and subsequently adopted as a standard of care by 2020.

In April 2021 the company merged with Ambulatory Neurological Services, expanding national coverage, and in March 2021 it established a Middle East joint venture to initiate international expansion. The company has subsequently broadened its commercial footprint through a UnitedHealthcare in-network designation in September 2024 and partnerships with Assure Neuromonitoring (June 2023) and Synthesys Brain Health (October 2023), the latter extending the business into CNS clinical trials and drug-development endpoints. Neurovative employs between 101 and 250 people and reports a referral network spanning thousands of hospitals, facilities, and physicians.

Name

Neurovative Diagnostics

Legal name

Neurovative Diagnostics

Website

https://neurovativediagnostics.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

101–250 employees

Short description

Neurovative Diagnostics is a Dallas-based, Joint Commission-accredited provider of in-home ambulatory video EEG monitoring services delivered through a cloud-based platform, serving hospitals, physicians, private practices, and patients across the United States.

Ownership category

akta.pro rank

Product category

Neurodiagnostic Services

NAICS

Diagnostic Imaging Centers (621512), Medical and Diagnostic Laboratories (62151), Home Health Care Services (62161)

SIC

Services-Medical Laboratories (8071), Services-Health Services (8000)

akta.pro primary industry

Neurodiagnostic Centers (EEG/EMG/NCS) (HLAFAKAK)

akta.pro secondary industries

Neurology Telemedicine Platforms (HLALAGAC), Neurology RPM (epilepsy, Parkinson’s, MS monitoring) (HLALAFAJ)

Keywords

• Ambulatory EEG monitoring
• Neurodiagnostic services
• In-home video EEG
• EEG interpretation services
• Quantitative EEG analysis

Headquarters

HQ city

Dallas

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Neurodiagnostic EEG Services: Provides intermittent live EEG, continuous inpatient EEG, in-home long-term EEG monitoring, and daily EEG review services. Professional interpretation by board-certified neurologists.
2. Equipment & Software Solutions: Access to state-of-the-art EEG equipment and software for reliable and efficient data collection and analysis.
3. Clinical Trials EEG Data: Adds real-time EEG data to clinical trials for successful drug development in CNS research.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Neurovative Diagnostics provides in-home ambulatory video and EEG monitoring services for patients with neurological conditions, leveraging a proprietary cloud-based platform that enables real-time physician review and continuous remote monitoring. The company delivers diagnostic services including intermittent live monitoring, continuous inpatient EEG, long-term in-home EEG, quantitative EEG analysis, daily reports, and board-certified neurologist interpretation to hospitals, physicians, long-term care facilities, and clinical trial sponsors.

Product overview

Neurovative Diagnostics operates as a cloud-based EEG platform offering a unified suite of neurodiagnostic services accessible on any device with national coverage. The core portfolio includes intermittent and continuous inpatient EEG monitoring, in-home long-term ambulatory video-EEG, and daily EEG review with physician interpretation. Supporting services include quantitative EEG (qEEG/ERP) analysis for advanced brain activity insights, EEG equipment and software solutions, specialized clinical trials support, and professional EEG training programs. The platform is accessible via their web portal at eeg.neurovativediagnostics.com, serving hospitals, long-term facilities, private practices, and individual patients across the United States.

Differentiator

Problem solved

Functional benefit

Products and services

• Intermittent Live EEG Monitoring
• Continuous Inpatient EEG Live Monitoring
• In-Home Long-Term EEG
• Daily EEG Review & Reports
• Quantitative EEG (qEEG/ERP)
• Equipment & Software Solutions
• Physician Interpretation Services
• EEG Training
• Clinical Trials EEG Services

Quantifiable outcome

• Intermittent monitoring real-time reviews every 90 minutes during entire recording period

Named customers2 records

Segments3 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered major, core, flagship and strategic.

• UnitedHealthcare (UHC)majorChannel Partner/ Reseller/ Distributor · 11 September 2024Neurovative Diagnostics became an in-network provider for all UnitedHealthcare products, expanding insurance coverage options for patients and increasing referral volume from UHC-network physicians.
• Synthesys Brain HealthcoreStrategic or Co-development Partner · 13 October 2023Partnership focused on EEG in CNS drug development, delivering high-quality and high-impact EEG data for clinical trials and pharmaceutical research.
• Assure NeuromonitoringcoreStrategic or Co-development Partner · 28 June 2023Assure Neuromonitoring expanded service offerings to address the high growth EEG services market through this partnership with Neurovative Diagnostics.
• Ambulatory Neurological ServicesflagshipStrategic or Co-development Partner · 8 April 2021Neurovative Diagnostics and Ambulatory Neurological Services merged to create an industry-leading EEG service provider, combining expertise and expanding service capabilities.
• Middle East Venture PartnersstrategicStrategic or Co-development Partner · 30 March 2021Neurovative Diagnostics partnered in a Middle East venture to expand access to care by lending expertise in operations, staffing, and education for patients with epilepsy in the region.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• BioSerenity: BioSerenity provides in-home and ambulatory EEG and remote neurology diagnostics. Direct competitor to Neurovative's in-home long-term EEG and cloud-based EEG platform, serving similar epileptologist and neurology customers.
• Stratus EEG: Stratus EEG provides ambulatory EEG and remote EEG interpretation services nationally. Closely comparable to Neurovative's intermittent live monitoring, in-home EEG, and physician interpretation offerings.
• CortiCare: CortiCare offers continuous inpatient EEG monitoring, remote EEG reading, and ICU EEG services. Overlaps directly with Neurovative's continuous inpatient EEG live monitoring and physician interpretation lines.
• Assure Neuromonitoring: Assure Neuromonitoring provides intraoperative neurophysiological monitoring and EEG services, and is also a Neurovative partner (2023). Competes in adjacent EEG and neurodiagnostic service lines targeting hospitals and physicians.

Emerging players

• Ceribell: Ceribell delivers point-of-care EEG and AI-powered seizure detection for inpatient use. Addresses the same hospital neurology customer segment as Neurovative but with a hardware/software focus rather than a service model.
• Wave Neuroscience: Wave Neuroscience offers quantitative EEG-based assessment and neurofeedback services. Compares as an emerging player applying advanced EEG analytics — overlapping with Neurovative's qEEG/ERP offering.
• Persyst (now part of Excelra): Persyst develops EEG review and seizure detection software widely used in clinical EEG. Compares as an emerging enabling player whose software stack supports ambulatory and inpatient EEG similar to Neurovative's platform.

Broad incumbents

• Natus Medical (Nihon Kohden): Natus (acquired by Nihon Kohden) manufactures and supports EEG equipment and neurodiagnostic software used across hospitals and ambulatory providers. Compares as a broad incumbent in the neurodiagnostic equipment and software stack Neurovative leverages.
• Compumedics: Compumedics is a global neurodiagnostic device and software company offering EEG, sleep, and brain monitoring systems. Compares as a broader incumbent providing the equipment category in which Neurovative operates.
• Cadwell Industries: Cadwell designs and sells neurodiagnostic equipment including EEG systems. Adjacent incumbent supplying EEG hardware and software infrastructure to providers like Neurovative and its customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCfvgahNS4vIDdPrvV6qcRfw
• Facebookfacebook.com/neurovativediagnostics
• LinkedInlinkedin.com/company/neurovative-diagnostics
• Instagraminstagram.com/neurovativediagnostics

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neurovative Diagnostics